🔎 Trials Near Me

Home › Clear-cell metastatic renal cell carcinoma › Tennessee › Nashville

Clear-cell metastatic renal cell carcinoma clinical trials in Nashville, TN

5 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

RecruitingPhase 3
  • Research Site, Nashville
  • Research Site, Nashville
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07011719

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

RecruitingPhase 1
  • Vanderbilt University Medical Center, Nashville
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT07748988

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

RecruitingPhase 1/2
  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Tennessee Oncology, PLLC- Elliston Place Plaza, Nashville
  • and 11 more
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07227415

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

RecruitingPhase 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05361720

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

RecruitingPhase 1
  • SCRI Oncology Partners, Nashville
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07195682

Clear-cell metastatic renal cell carcinoma trials in other cities

Other studies in Nashville

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.